Manulife (Manufacturers Life Insurance)’s Co-Diagnostics CODX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-499
Closed -$143K 3230
2021
Q1
$143K Sell
499
-39
-7% -$15.6K ﹤0.01% 2989
2020
Q4
$150K Buy
538
+21
+4% +$7.78K ﹤0.01% 2861
2020
Q3
$211K Hold
517
﹤0.01% 2528
2020
Q2
$270K Buy
+517
New +$236K ﹤0.01% 2319

Other funds holding CODX

Manulife (Manufacturers Life Insurance)'s CODX Position: Q2 2021 in Review

Manulife (Manufacturers Life Insurance) sold out of Co-Diagnostics (CODX) in Q2 2021, closing a stake of 499 shares — an estimated $143K sold.

Manulife (Manufacturers Life Insurance) first reported a position in CODX in Q2 2020 and held it in 4 quarters. The position peaked at $270K in Q2 2020. 88 funds tracked by Wall St. Rank hold CODX as of Q2 2021.

  • Manulife (Manufacturers Life Insurance) reported no remaining Co-Diagnostics position as of Q2 2021 after selling out during the quarter.
  • Manulife (Manufacturers Life Insurance) sold 499 Co-Diagnostics shares in Q2 2021, an estimated $143K.
  • Manulife (Manufacturers Life Insurance) first reported a position in Co-Diagnostics in Q2 2020 and held it in 4 quarters.
  • Manulife (Manufacturers Life Insurance)'s Co-Diagnostics position peaked at $270K in Q2 2020.
  • 88 funds tracked by Wall St. Rank held Co-Diagnostics as of Q2 2021.

Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q2 2021, filed 12 Aug 2021.